Free public records show Resurge Therapeutics Inc. in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Resurge Therapeutics Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
3 active studies led by Resurge Therapeutics Inc., of 3 in all
Source: ClinicalTrials.gov, Studies with Resurge Therapeutics Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies Resurge Therapeutics Inc. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Resurge Therapeutics Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Resurge Therapeutics Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Resurge Therapeutics Inc. is in.
Stories on the topics Resurge Therapeutics Inc. works in.
Only about a quarter of testosterone booster products had study data showing they raise testosterone. Sexual…
Read
About 1 in 6 adults experience infertility. In many countries one IVF cycle costs more than a year's income.
Read
In 2022 the FDA approved the first pill for severe alopecia areata, which affects more than 300,000 people in…
ReadSearch all reports for Resurge Therapeutics Inc. All companies